There is growing interest in how tau is catabolized in the Alzheimer's disease (de Vrij et al., 2004; Chesser et al., 2013; Tarasoff-Conway et al., 2015; Vaz-Silva et al., 2018; Xin et al., 2018; Liu et al., 2021). This evidence concerns the gene MAPT and Alzheimer disease.